In this webinar, we will cover:
1. Background on Hepatocellular Carcinoma and how the liver microenvironment affects the immune cells
2. Relevant examples of successful/promising immunotherapies in hepatocellular carcinoma patients (cytokines, mAbs, TILs, CARs)
3. Our hypothesis: successful immunotherapy depends on targeting the relevant antigens
4. Our screening model: focus on specific genes that are clinically relevant for the tumor progression and identify T cell receptors able to recognize neoantigens within those genes
